Complexity Brings Bad Times for Single-Gene Biotech Industry

Geneticists might have been simple, but they weren’t dumb. Earlier this month, the New York Times ran a breathless article about new discoveries in genetics:The $73.5 billion global biotech business may soon have to grapple with a discovery that calls into question the scientific principles on which it was founded.

MORE ON THIS TOPIC